Hero image

About our company

We invent for a more hopeful future.

We aspire to be the premier research-intensive biopharmaceutical company in the world

For 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

women harvesting tea leaves with basket
Responsibility

The heart of our mission

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Illustration of leaders speaking on stage
Leadership

The team that guides our work

Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

74K

employees

Our culture
$13.6B

research and development investment in 2020

Our research
$3.1B

total philanthropy in 2019

Our giving
group of scientists working together in lab
Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Living with type 2 diabetes in uncertain times

One man’s story of finding support for managing his type 2 diabetes during the pandemic

Read more

Next: Living with type 2 diabetes in uncertain times

Helping professionals return to the workforce after a career break

MSD is offering returnships for the untapped talent pool who decide to take career breaks

Read more

Next: Helping professionals return to the workforce after a career break

Dr. Fauci on the HIV/AIDS epidemic: Ending it by 2030 is “doable”

Dr. Anthony Fauci, director of NIAID, sits down with MSD’s Dr. Julie Gerberding to reflect on early HIV innovations and the challenges that still remain in ending the epidemic

Read more

Next: Dr. Fauci on the HIV/AIDS epidemic: Ending it by 2030 is “doable”

Finding the courage to come out after 20 years of marriage

Last June, MSD executive Scott M. Wright shared his story of coming out in midlife — the response was overwhelming

Read more

Next: Finding the courage to come out after 20 years of marriage

Progress in ovarian cancer research – it starts with the patients

Scot Ebbinghaus, vice president, clinical research

Read more

Next: Progress in ovarian cancer research – it starts with the patients

Living with type 2 diabetes in uncertain times

One man’s story of finding support for managing his type 2 diabetes during the pandemic

Read more

Next: Living with type 2 diabetes in uncertain times

Helping professionals return to the workforce after a career break

MSD is offering returnships for the untapped talent pool who decide to take career breaks

Read more

Next: Helping professionals return to the workforce after a career break

Dr. Fauci on the HIV/AIDS epidemic: Ending it by 2030 is “doable”

Dr. Anthony Fauci, director of NIAID, sits down with MSD’s Dr. Julie Gerberding to reflect on early HIV innovations and the challenges that still remain in ending the epidemic

Read more

Next: Dr. Fauci on the HIV/AIDS epidemic: Ending it by 2030 is “doable”

Finding the courage to come out after 20 years of marriage

Last June, MSD executive Scott M. Wright shared his story of coming out in midlife — the response was overwhelming

Read more

Next: Finding the courage to come out after 20 years of marriage

Progress in ovarian cancer research – it starts with the patients

Scot Ebbinghaus, vice president, clinical research

Read more

Next: Progress in ovarian cancer research – it starts with the patients

Previous
Next

Our areas of focus

We focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our response to COVID-19

Cardio-metabolic disorders

We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.

Learn about cardio-metabolic disorders

Discovery & development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work

Dog owner holding out a ball for an attentive Labrador

MSD Animal Health

MSD Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.

We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

Business partnerships and public policies keep our patients in focus

Column one image

Business development & licensing

We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Column one image

Policies & positions

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.